Figure 5From: Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma Kaplan-Meier curves of AEG-1 expression against overall survival of PDAC patients. The data were analyzed using a log-rank test between patients with low AEG-1 expressed PDAC (full line) versus high AEG-1-expressed PDAC (dotted line). The cumulative 2-year survival rate was 38.09% in patients with low AEG-1-expressed PDAC (n = 46) compared to only 7.84% in patients with high AEG-1-expressed PDAC (n = 59).Back to article page